Cargando…
An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection
BACKGROUND: The use of octreotide prophylaxis following pancreatic surgery is controversial. We aimed to evaluate the effectiveness of octreotide for the prevention of postoperative complications after pancreatic surgery through this systematic review and meta-analysis. METHODS: Literature databases...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756593/ https://www.ncbi.nlm.nih.gov/pubmed/31567967 http://dx.doi.org/10.1097/MD.0000000000017196 |
_version_ | 1783453426080808960 |
---|---|
author | Zheng, Hao Qin, Jiwei Wang, Ning Chen, Wanjing Huang, Qiang |
author_facet | Zheng, Hao Qin, Jiwei Wang, Ning Chen, Wanjing Huang, Qiang |
author_sort | Zheng, Hao |
collection | PubMed |
description | BACKGROUND: The use of octreotide prophylaxis following pancreatic surgery is controversial. We aimed to evaluate the effectiveness of octreotide for the prevention of postoperative complications after pancreatic surgery through this systematic review and meta-analysis. METHODS: Literature databases (including the MEDLINE, EMBASE, and Cochrane databases) were searched systematically for relevant articles. Only randomized controlled trials (RCTs) were eligible for inclusion in our research. We extracted the basic information regarding the patients, intervention procedures, and all complications after pancreatic surgery and then performed the meta-analysis. RESULTS: Thirteen RCTs involving 2006 patients were identified. There were no differences between the octreotide group and the placebo group with regard to pancreatic fistulas (PFs) (relative risk [RR] = 0.79, 95% confidence interval [CI] = 0.62–0.99, P = .05), clinically significant PFs (RR = 1.01, 95% CI = 0.68–1.50, P = .95), mortality (RR = 1.21, 95% CI = 0.78–1.88, P = .40), biliary leakage (RR 0.84, 95% CI = 0.39–1.82, P = .66), delayed gastric emptying (RR = 0.83, 95% CI = 0.54–1.27, P = .39), abdominal infection (RR = 1.00, 95% CI = 0.66–1.52, P = 1.00), bleeding (RR = 1.16, 95% CI = 0.78–1.72, P = .46), pulmonary complications (RR = 0.73, 95% CI = 0.45–1.18, P = .20), overall complications (RR = 0.80, 95% CI = 0.64–1.01, P = .06), and reoperation rates (RR = 1.18, 95% CI = 0.77–1.81, P = .45). In the high-risk group, octreotide was no more effective at reducing PF formation than placebo (RR = 0.81, 95% CI = 0.67–1.00, P = .05). In addition, octreotide had no influence on the incidence of PF (RR = 0.38, 95% CI = 0.14–1.05, P = .06) after distal pancreatic resection and local pancreatic resection. CONCLUSION: The present best evidence suggests that prophylactic use of octreotide has no effect on reducing complications after pancreatic resection. |
format | Online Article Text |
id | pubmed-6756593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-67565932019-10-07 An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection Zheng, Hao Qin, Jiwei Wang, Ning Chen, Wanjing Huang, Qiang Medicine (Baltimore) 7100 BACKGROUND: The use of octreotide prophylaxis following pancreatic surgery is controversial. We aimed to evaluate the effectiveness of octreotide for the prevention of postoperative complications after pancreatic surgery through this systematic review and meta-analysis. METHODS: Literature databases (including the MEDLINE, EMBASE, and Cochrane databases) were searched systematically for relevant articles. Only randomized controlled trials (RCTs) were eligible for inclusion in our research. We extracted the basic information regarding the patients, intervention procedures, and all complications after pancreatic surgery and then performed the meta-analysis. RESULTS: Thirteen RCTs involving 2006 patients were identified. There were no differences between the octreotide group and the placebo group with regard to pancreatic fistulas (PFs) (relative risk [RR] = 0.79, 95% confidence interval [CI] = 0.62–0.99, P = .05), clinically significant PFs (RR = 1.01, 95% CI = 0.68–1.50, P = .95), mortality (RR = 1.21, 95% CI = 0.78–1.88, P = .40), biliary leakage (RR 0.84, 95% CI = 0.39–1.82, P = .66), delayed gastric emptying (RR = 0.83, 95% CI = 0.54–1.27, P = .39), abdominal infection (RR = 1.00, 95% CI = 0.66–1.52, P = 1.00), bleeding (RR = 1.16, 95% CI = 0.78–1.72, P = .46), pulmonary complications (RR = 0.73, 95% CI = 0.45–1.18, P = .20), overall complications (RR = 0.80, 95% CI = 0.64–1.01, P = .06), and reoperation rates (RR = 1.18, 95% CI = 0.77–1.81, P = .45). In the high-risk group, octreotide was no more effective at reducing PF formation than placebo (RR = 0.81, 95% CI = 0.67–1.00, P = .05). In addition, octreotide had no influence on the incidence of PF (RR = 0.38, 95% CI = 0.14–1.05, P = .06) after distal pancreatic resection and local pancreatic resection. CONCLUSION: The present best evidence suggests that prophylactic use of octreotide has no effect on reducing complications after pancreatic resection. Wolters Kluwer Health 2019-09-20 /pmc/articles/PMC6756593/ /pubmed/31567967 http://dx.doi.org/10.1097/MD.0000000000017196 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 7100 Zheng, Hao Qin, Jiwei Wang, Ning Chen, Wanjing Huang, Qiang An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection |
title | An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection |
title_full | An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection |
title_fullStr | An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection |
title_full_unstemmed | An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection |
title_short | An updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection |
title_sort | updated systematic review and meta-analysis of the use of octreotide for the prevention of postoperative complications after pancreatic resection |
topic | 7100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756593/ https://www.ncbi.nlm.nih.gov/pubmed/31567967 http://dx.doi.org/10.1097/MD.0000000000017196 |
work_keys_str_mv | AT zhenghao anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT qinjiwei anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT wangning anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT chenwanjing anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT huangqiang anupdatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT zhenghao updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT qinjiwei updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT wangning updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT chenwanjing updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection AT huangqiang updatedsystematicreviewandmetaanalysisoftheuseofoctreotideforthepreventionofpostoperativecomplicationsafterpancreaticresection |